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Induction of Plasminogen Activator in Cultured Cells by Macrocyclic Plant
Diterpene Esters and Other Agents Related to Tumor Promotion1
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ABSTRACT
In vitro systems that are responsive to tumor-promoting
agents may facilitate the identification of such agents and
the analysis of their mode of action. We have previously
reported that the potent tumor promoter phorbol-12-myr-
istate-13-acetate induces the synthesis of the enzyme
plasminogen activator in cultured chick embryo fibro-
blasts. We have, therefore, tested various compounds for
their ability to induce plasminogen activator in chicken
embryo fibroblasts. Among these, phorbol esters and
other macrocyclic diterpene esters isolated from species
of the families Euphorbiaceae and Thymelaeaceae were
potent inducers of plasminogen activator. These com
pounds maximally induced enzyme to the same levels,
although they differed in their relative molar potencies.
Structural requirements for in vitro activity paralleled the
requirements for activity in vivo. These results indicate
that induction of plasminogen activator is a useful marker
for the biologically active macrocyclic diterpene esters.
On the other hand, tumor-promoting agents such as an-
thralin, cantharidin, Tween 60, and tobacco leaf extract
failed to induce plasminogen activator.
INTRODUCTION
Tumor promoters have been defined as agents that are
not in themselves carcinogenic but that significantly in
crease tumor incidence in animals pretreated with carcino
gens. The existence of tumor promoters was first rigorously
demonstrated by Berenblum and Shubik (3), who used the
2-stage carcinogenesis protocol for the identification of
promoting agents. The overall contribution of tumor-pro
moting substances of natural or industrial origin to the
incidence or rate of progression of human cancer is un
known, but epidemiological evidence and data from animal
studies suggest their potential relevance in several forms of
carcinoma (12, 20, 29). An understanding of this phenome
non and the identification of etiological agents is therefore
of considerable importance.
The phorbol esters, macrocyclic diterpene esters found
in the seed oil of Croton tiglium, a leafy shrub of the family
Euphorbiaceae, are the most potent known promoting
agents (10). In addition to their tumor-promoting activity in
mouse skin, nanomolar concentrations of phorbol esters
affect cultured cells, altering growth properties and mor
phology (8), increasing phospholipid synthesis (26), induc
ing plasminogen activator (30, 31) and ornithine decarbox-
ylase (33), and inhibiting cellular differentiation (6, 21, 32).
The availability of in vitro systems responsive to the phorbol
esters provides an opportunity to analyze the biochemical
origin of activity of these compounds under well-defined
conditions. In addition, in vitro systems may facilitate the
assay of suspected promoting agents. With these ends in
mind, we have tested various compounds for their ability to
induce plasminogen activator in cultured cells. Three cate
gories of compounds were examined: (a) phorbol, its esters
and derivatives with known tumor-promoting activity; (b)
macrocyclic plant diterpene esters from the families Thy
melaeaceae and Euphorbiaceae, which are structurally sim
ilar to the phorbol esters and have been identified as
antileukemic principles (14-17); and (c) tumor promoters
and cocarcinogens of diverse origin.
MATERIALS AND METHODS
Phorbol, PMA,2 4-O-methyl-PMA, phorbol-12,13-dideca-
noate, and 4a-PDD were obtained from Consolidated Mid
land, Brewster, N. Y.; Tween 60 and cantharidin were from
Sigma Chemical Co., St. Louis, Mo.; nicotine was from
Aldrich Chemical Co., Milwaukee, Wis.; anthralin was the
generous gift of Dr. Sydney Belman; cigarette smoke con
densate, fractions, and reconstituted smoke condensate
prepared according to the method of Swain ef al. (27) were
generous gifts of Dr. William Benedict; barium hydroxide
extracts of tobacco (Pall Mall) were prepared according to
published methods (5); asbestos fibers (amosite, crocidol-
ite, and chrysotile) were in accord with IUCC standards and
were the generous gift of Dr. A. Langer; ingenol-3,20-
dibenzoate, phorbol-12-tiglate-13-decanoate, G-1, gnidi-
macrin-20-palmitate, G-20, gnidilatin-20-palmitate, G-5, and
gnilatimacrin-20-palmitate were generous gifts of Dr. Morris
Kupchan.
CEF and HeLa cells were grown as monolayer cultures in
Eagle's minimal essential medium supplemented with 5%
fetal calf serum (Grand Island Biological Co., Grand Island,
N. Y.) in a humidified incubator at 37Â°under an atmosphere
of 5% CO.. CEF were prepared by standard procedures
from 9- to-12-day chick embryos (23) and were used be
tween the third and the ninth passage.
Plasminogen activator was assayed by published meth
ods (31). The assay is based on quantitation of solubiliza-
tion of 125l-labeledfibrin due to proteolytic digestion in the
' Supported by Contract NO-1-CP-2-3234 of the National Cancer Institute,
Department of Health. Education and Welfare.
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2The abbreviations used are: PMA, phorbol-12-myristate-13-acetate (also
called 12-O-tetradecanoylphorbol-13-acetate); 4-O-methyl-PMA, 4-O-methyl-
phorbol-12-myristate-13-acetate; 4Â«-PDD,4a-phorbol-12,13-didecanoate; G-
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presence of plasminogen and sample. For the experiments
described here, the sample was a lysate of cells prepared
as described previously (31). Plasminogen was prepared
from outdated human plasma (7), and 125l-labeled fibrin-
coated dishes were prepared as described by Unkeless ei
al. (28).
For the purpose of assaying the induction of plasminogen
activator by various compounds, CEF from third- to eighth-
passage cultures were exposed to test agents for either 12
hr in the absence of serum or 24 hr in the presence of
serum. At the end of this time, cell lysates were prepared as
previously described (31) and were stored frozen until
assayed for plasminogen activator. Induction of plasmino
gen activator by phorbol esters is slower in the presence of
serum that in its absence but reaches the same level of
induction under both conditions in 24 and 12 hr, respec
tively (unpublished work). More importantly, the presence
or absence of serum does not affect the dose-response
curve of CEF to the phorbol esters.
RESULTS
Table 1 summarizes the response of CEF to phorbol, its
esters and derivatives, and to a series of macrocyclic plant
diterpene esters isolated from members of the families
Euphorbiaceae and Thymelaeaceae, which have been char
acterized as antileukemic agents. Cells were exposed to
varying concentrations of each agent for 12 hr, and the
amount of activity in cellular lysates was determined. In
Chart 1, typical dose-response curves are plotted for a few
of the compounds studied. With the most potent com
pounds, induction occurs in the nanomolar range. Maxi
mum-fold induction observed is within a factor of 2 for each
active compound, and the level of induction plateaus for all
compounds studied at sufficiently high concentrations. The
level of induction observed in CEF treated with these corn-
Table 1
Induction of plasminogen activator by phorbol, phorbol esters,
and other macrocyc/ic plant diterpenes
CEF were exposed to agents over a broad range of concentra
tions, and the amount of plasminogen activator in cell lysates was
determined as described (31). ED5Uwas determined as the dose
producing 50% of maximal induction. See text for details and
references.
CompoundPhorbolPMA4-O-Methyl
PMAPhorbol-12,13-didecanoate4a-PDDPhorbol-12-tiglate,
13-decanoatelngenol-3,20-dibenzoateMezereinG-1Gnidimacrin-20-palmitate
(G-25)G-5Gnilatimacrin-20-palmitate
(G-18)G-20Gnidilatin-20-palmitate
(G-21)ED..,,
Biological(x 10~* M)activity>26,0007.81507.1>
1,40043181.51.21003.1563.056nftcbcddddddddd
O I IO IO0
CONCENTRATION (NANOGRAMS/ML)
IOO
" Inactive as tumor promoter.
* Potent tumor promoter.
c Reportedly inactive as tumor promoter.
rf Antileukemic.
Chart 1. The induction of plasminogen activator in CEF by varying con
centrations of macrocyclic plant diterpene esters. Subconfluent plates of
CEF were exposed to the indicated agents for 12 hr in the absence of serum.
Cellular lysates were prepared and plasminogen activator levels were mea
sured as percentage of fibrinolysis, as indicated in the text. IDB, ingenol
dibenzoate; PTD, phorbol-12-tiglate-13-decanoate; G-25, gnidimacrin-20-
palmitate.
pounds does not represent the maximum level of synthesis
of which these cells are capable. When CEF infected with
Rous sarcoma virus are treated with PMA, they produce
plasminogen activator levels 10 to 40 times higher than
when uninfected cells are similarly treated (30). From data
such as those shown in Chart 1, a dose that produced 50%
of the maximum effect can be estimated for each com
pound, and these values are indicated in Table 1. Of the
compounds tested, only 4a-PDD (up to 1.4 x 10 6 M) and
phorbol (up to 2.5 x 10s M) were completely inactive.
The structures of the compounds tested are shown in
Chart 2. Three different macrocyclic ring structures (phor
bol, mezerein, and ingenol) have activity, and all share a
common 7-membered ring in a fixed orientation to a 5-
membered ring. Mezerein, G-1, G-20, and G-5 are as potent
or more so than is PMA. When the Cj,,alcohols of the gnidia
compounds (G-1, G-20, and G-5 are esterified (gnidima-
crin-20-palmitate, gnidilatin-20-palmitate, gnilatimacrin-20-
palmitate), molar potency is reduced 20- to 100-fold.
Listed in Table 2 are miscellaneous agents that we tested
for induction of activity in CEF or HeLa. Cultures of CEF or
HeLa were treated with the indicated agent for 24 hr in the
presence of serum and plasminogen activator levels deter
mined in cellular lysates. For each experiment, cultures
treated with 5 x 10~8 M PMA were included as positive
controls. The tumor-promoting agents anthralin (4), can-
tharidin (13), an Tween 60 (25) were tested as were the
asbestos fibers amosite, crocidolite, and chrysotile, which
may act as cocarcinogens (24) and are reported to induce
plasminogen activator in mouse peritoneal macrophages
(9). These compounds did not induce plasminogen activa
tor in CEF or HeLa. Extracts of tobacco leaf and cigarette
smoke condensate have been repeatedly shown to possess
tumor-promoting activity in mouse skin (5, 29). In addition,
both tobacco extracts and smoke condensate contain ma
crocyclic diterpenes, similar in structure to phorbol (22).
For these reasons, we tested a barium hydroxide extract of
tobacco with demonstrated promoting activity (5), an ex-
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Chart 2. Structures of some macrocyclic plant diterpenes derived (A and
B) from the families Euphorbiaceae (Al and All) and Thymelaeaceae (AllÃ-
and B).
tract of cigarette smoke condensate, and various chemical
fractions of the latter according to the scheme of Swain ef
al. (27) for the ability to induce plasminogen activator in
either CEF of HeLa. None of the extracts of fractions thereof
exhibited biological activity characteristic of the phorbol
esters.
DISCUSSION
Plasminogen activator is a serine protease that specifi
cally cleaves plasminogen to plasmin, the major fibrinolytic
factor in blood (28). Measurable levels of plasminogen
activator are found in a variety of body tissues as well as in
cell and organ cultures (1). In a previous paper (31), we
reported on the induction of the enzyme in cultured CEF
Table 2
Agents that fail to induce plasminogen activator in CEF or HeLa
Cells were exposed to agents for 24 hr in the presence of
medium with serum, cell lysates were prepared, and plasminogen
activator was assayed as described.
AgentPMAAnthralinCantharidinTween
60Asbestos
AmositeCrocidolite
ChrysotileTobacco,
Ba(OH2)extractCigarette
smoke conden
sate, dimethyl sulfox-
ideextractCigarette
smoke conden
satefractions0Cigarette
smoke reconsti
tute''NicotineDose
(/Â¿g/ml)0.031-3010-100
1-3010-10000.1-10
0.1-10
0.1-1030-100025-755-203-30100-1000CellCEF
HeLaCEF
HeLaCEF
HeLaCEF
HeLaCEF
CEF
CEFHeLaCEF
HeLaCEF
HeLaCEF
HeLaCEFInduc
tion"+"
+NS
NSNS
NSNS
NSNS
NS
NSNSNS
NSNS
NSNS
NSNS
" In each experiment, cultures of CEF and HeLa were exposed
to PMA (30 ng/ml) as a positive control for induction.
* +, greater than 10% fibrinolysis in 3 hr; NS, no significant
activity above untreated cultures (less than 1% fibrinolysis in 3 hr).
0 All 12 fractions of cigarette smoke condensate were tested
according to the fractionation scheme of Swain ef al. (27).
'' Fractions were pooled (27).
and HeLa cells by the potent tumor promoter phorbol-12-
myristate-13-acetate. We report here the results of tests of
additional phorbol esters and derivatives, promoters of
diverse origins, and related agents.
The potent tumor-promoting phorbol esters PMA and
phorbol-12,13-didecanoate were both potent inducers of
plasminogen activator while phorbol was completely in
active (2). 4-0-methyl-PMA, which has been reported to be
inactive as a tumor promoter in mouse (18), was active in
our system, although only at relatively high concentrations.
It is thus possible that this compound was not tested for
tumor promotion at sufficiently high doses. Consistent with
our finding is the report that 4-O-methyl-PMA induces
ornithine decarboxylase in cultures of mouse epidermal
cells (33). 4Â«-PDDis claimed to be inactive as a tumor
promoter (E. Hecker, personal communication), yet Mondai
et al. (19) find that it promotes chemical transformation of
mouse 10T'/2 cells in vitro. We find 4<*-PDDto be inactive
as an inducer of plasminogen activator in CEF. We feel that
the discrepancies in the in vitro and in vivo systems merit
further investigation.
In addition to the above compounds, we have tested
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macrocyclic diterpene esters extracted from plants of the
families Euphorbiaceae and Thymelaeaceae which are
structurally related to the phorbol esters and have antileu-
kemic activity (14-17). These compounds were all potent
inducers of plasminogen activator, demonstrating that in
duction in cultured CEF can be used as a specific indicator
for the biologically active macrocyclic plant diterpene es
ters. The active compounds have highly lipophilic fatty acid
esters or orthoesters and a C2I,primary alcohol. When the
C2(,alcohol of the gnidia compounds is esterified, the
compounds become 20- to 100-fold less active on a molar
basis. Loss of tumor-promoting activity also occurs on
esterifÂ¡cation of the CÃŽHalcohol of the phorbol esters (10).
Structural requirements for/n vitro activity parallel, at least
in part, the requirements for activity in vivo. Macrocyclic
diterpene esters of the gnidia class have not in general
been studied for promoting activity. Mezerein, which we
have found to be more potent than PMA in the induction
of plasminogen activator in CEF, does promote in mouse
skin, although weakly (11).
Cocarcinogens and promoting agents thought to be un
related to the phorbol esters were tested for the ability to
induce plasminogen activator. Anthralin, cantharidin, and
Tween 60 do not induce. Asbestos fibers, which have been
reported to induce plasminogen activator synthesis in
mouse peritoneal macrophage (9), do not induce plasmin
ogen activator in CEF. Cigarette smoke condensÃ¢tes and
extracts of tobacco, which are tumor promoting in mouse
skin (5, 29), similarly fail to induce the enzyme in CEF or
HeLa. Induction of plasminogen activator in vitro thus does
not reflect the full complexity of events governing promo
tion. The reasons for this may be varied: the particular cell
lines used in this study may not be sensitive to the agents
tested due to metabolism or failure to metabolize or due to
the absence of an appropriate receptor; in complex mix
tures, such as tobacco smoke condensÃ¢tes, the active
agent may be present but below the threshold of detection,
or inhibiting agents may also be present; and finally, it is
possible that the promoting activities of anthralin, canthar
idin, Tween 60, and tobacco extracts are mediated by
different mechanisms than that of the phorbol esters. Since
tumor promotion may require a complex interaction be
tween multiple cell types and multiple responses, it may not
be possible for any one in vitro assay system to predict the
promoting activity of all classes of suspected promoting
agents. The great variety of agents that evoke somewhat
different responses, however, should facilitate an under
standing of the events that comprise tumor promotion.
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